JP2001501936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001501936A5 JP2001501936A5 JP1998516942A JP51694298A JP2001501936A5 JP 2001501936 A5 JP2001501936 A5 JP 2001501936A5 JP 1998516942 A JP1998516942 A JP 1998516942A JP 51694298 A JP51694298 A JP 51694298A JP 2001501936 A5 JP2001501936 A5 JP 2001501936A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2732096P | 1996-10-02 | 1996-10-02 | |
| US60/027,320 | 1996-10-02 | ||
| US4377697P | 1997-04-11 | 1997-04-11 | |
| US60/043,776 | 1997-04-11 | ||
| PCT/US1997/018001 WO1998014192A1 (en) | 1996-10-02 | 1997-10-01 | Vitronectin receptor antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009235447A Division JP2010006838A (ja) | 1996-10-02 | 2009-10-09 | ビトロネクチンレセプター拮抗物質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001501936A JP2001501936A (ja) | 2001-02-13 |
| JP2001501936A5 true JP2001501936A5 (https=) | 2005-05-12 |
| JP4491072B2 JP4491072B2 (ja) | 2010-06-30 |
Family
ID=26702318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51694298A Expired - Fee Related JP4491072B2 (ja) | 1996-10-02 | 1997-10-01 | ビトロネクチンレセプター拮抗物質 |
| JP2009235447A Pending JP2010006838A (ja) | 1996-10-02 | 2009-10-09 | ビトロネクチンレセプター拮抗物質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009235447A Pending JP2010006838A (ja) | 1996-10-02 | 2009-10-09 | ビトロネクチンレセプター拮抗物質 |
Country Status (36)
| Country | Link |
|---|---|
| EP (1) | EP0957917B1 (https=) |
| JP (2) | JP4491072B2 (https=) |
| KR (1) | KR100589578B1 (https=) |
| CN (1) | CN1114403C (https=) |
| AP (1) | AP1463A (https=) |
| AR (1) | AR008878A1 (https=) |
| AT (1) | ATE312089T1 (https=) |
| AU (1) | AU733417B2 (https=) |
| BG (1) | BG64581B1 (https=) |
| BR (1) | BR9712248B1 (https=) |
| CA (1) | CA2267224C (https=) |
| CO (1) | CO4900046A1 (https=) |
| CY (1) | CY2576B1 (https=) |
| CZ (1) | CZ299076B6 (https=) |
| DE (1) | DE69734833T2 (https=) |
| DK (1) | DK0957917T3 (https=) |
| DZ (1) | DZ2320A1 (https=) |
| EA (1) | EA002419B1 (https=) |
| ES (1) | ES2252775T3 (https=) |
| HU (1) | HU229221B1 (https=) |
| ID (1) | ID19623A (https=) |
| IL (1) | IL129243A (https=) |
| MA (1) | MA24361A1 (https=) |
| MY (1) | MY137606A (https=) |
| NO (1) | NO320194B1 (https=) |
| NZ (1) | NZ334953A (https=) |
| PE (1) | PE10499A1 (https=) |
| PL (1) | PL190859B1 (https=) |
| RO (1) | RO119881B1 (https=) |
| SA (1) | SA98180936B1 (https=) |
| SK (1) | SK285029B6 (https=) |
| TR (1) | TR199900737T2 (https=) |
| TW (1) | TW487702B (https=) |
| UA (1) | UA60311C2 (https=) |
| UY (2) | UY24735A1 (https=) |
| WO (1) | WO1998014192A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
| TW527355B (en) | 1997-07-02 | 2003-04-11 | Bristol Myers Squibb Co | Inhibitors of farnesyl protein transferase |
| CN1273529A (zh) * | 1997-09-24 | 2000-11-15 | 史密丝克莱恩比彻姆公司 | 玻连蛋白受体拮抗剂 |
| AU9578798A (en) * | 1997-09-24 | 1999-04-12 | Smithkline Beecham Corporation | Vitronectin receptor antagonist |
| US6372719B1 (en) | 1998-03-04 | 2002-04-16 | Jay Cunningham | ανβ3 integrin antagonists in combination with chemotherapeutic agents |
| DE19842415A1 (de) * | 1998-09-16 | 2000-03-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
| AU2592600A (en) * | 1998-12-23 | 2000-07-31 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| AU747503B2 (en) * | 1999-02-03 | 2002-05-16 | Merck & Co., Inc. | Benzazepine derivatives as alpha-V integrin receptor antagonists |
| JP5127096B2 (ja) * | 1999-04-30 | 2013-01-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | アポトーシスにより誘導される自己免疫疾患を処置するためのベンゾジアゼピンの使用 |
| AU6523200A (en) * | 1999-08-06 | 2001-03-05 | Smithkline Beecham Corporation | Vitronectin receptor antagonists useful for the treatment of strokes |
| US6514964B1 (en) | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| DE10028575A1 (de) | 2000-06-14 | 2002-03-14 | Basf Ag | Integrinliganden |
| DE10027514A1 (de) * | 2000-06-06 | 2002-01-03 | Basf Ag | Liganden von Integrinrezeptoren |
| FR2806082B1 (fr) * | 2000-03-07 | 2002-05-17 | Adir | Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CA2436130A1 (en) | 2001-01-29 | 2002-08-08 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted indoles and their use as integrin antagonists |
| KR20030087069A (ko) * | 2001-04-10 | 2003-11-12 | 스미스클라인 비참 코포레이션 | 유착 형성을 억제하는 방법 |
| SE0101386D0 (sv) | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | New compounds |
| WO2002090325A2 (en) * | 2001-05-03 | 2002-11-14 | Merck & Co., Inc. | Benzazepinone alpha v integrin receptor antagonists |
| EP1443963B1 (en) | 2001-10-22 | 2014-05-21 | The Scripps Research Institute | Antibody targeting compounds |
| GB0215867D0 (en) * | 2002-07-09 | 2002-08-14 | Glaxosmithkline Spa | Novel method and compounds |
| WO2004089890A2 (en) * | 2003-04-04 | 2004-10-21 | Smithkline Beecham Corporation | Process and intermediates for preparing benzazepines |
| AU2005229015C1 (en) * | 2004-04-02 | 2013-01-17 | The Regents Of The University Of California | Methods and compositions for treating and preventing disease associated with alphaVbeta5 integrin |
| AU2012216372B2 (en) * | 2004-04-02 | 2015-01-22 | The Regents Of The University Of California | Methods and compositions for treating and preventing disease associated with alphaVbeta5 integrin |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| AR052823A1 (es) * | 2004-12-21 | 2007-04-04 | Smithkline Beecham Corp | Uso de un antagonista del receptor de vitronectina para l a preparacion de una formulacion farmaceutica util para inhibir el exceso de formacion de cicatrices en la piel de a un mamifero y dicha formulacion |
| EA016227B1 (ru) * | 2005-11-29 | 2012-03-30 | Смитклайн Бичем Корпорейшн | Способ лечения офтальмологических неоваскулярных расстройств |
| EP2730282A1 (en) | 2007-11-08 | 2014-05-14 | The General Hospital Corporation | Methods and compositions for the treatment of proteinuric diseases |
| AU2008321770B2 (en) * | 2007-11-16 | 2012-09-06 | Ube Industries, Ltd. | Benzazepinone compound |
| US8076475B2 (en) * | 2008-03-06 | 2011-12-13 | Glaxosmithkline Llc | Process |
| JP2012517447A (ja) | 2009-02-10 | 2012-08-02 | ザ スクリプス リサーチ インスティチュート | 化学的にプログラムされたワクチン接種法 |
| AU2010231631A1 (en) * | 2009-03-30 | 2011-11-10 | Ube Industries, Ltd. | Pharmaceutical composition for treatment or prevention of ophthalmic diseases |
| JP5572996B2 (ja) * | 2009-05-15 | 2014-08-20 | 宇部興産株式会社 | ベンズアゼピノン化合物を有効成分として含有する医薬 |
| EP2456460A4 (en) | 2009-07-24 | 2013-02-20 | Univ California | METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASES ASSOCIATED WITH AVB5 INTEGRIN |
| WO2011062765A2 (en) | 2009-11-17 | 2011-05-26 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| EP2325194A1 (en) * | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Process for the purification of glycoproteins |
| ES2864079T3 (es) | 2014-05-30 | 2021-10-13 | Pfizer | Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos |
| JP7693709B2 (ja) * | 2020-04-26 | 2025-06-17 | ジャンスー・エンファ・ファーマシューティカル・カンパニー・リミテッド | １，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用 |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2197160T3 (es) * | 1992-12-21 | 2004-01-01 | Smithkline Beecham Corp | Antagonistas fibronogeno bicicliclos. |
| NZ290008A (en) * | 1994-06-29 | 1998-08-26 | Smithkline Beecham Corp | Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle |
| ZA955391B (en) * | 1994-06-29 | 1996-02-09 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| JPH10504825A (ja) * | 1994-08-22 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | 二環式化合物 |
| WO1996026190A1 (en) * | 1995-02-22 | 1996-08-29 | Smithkline Beecham Corporation | Integrin receptor antagonists |
| UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
-
1997
- 1997-01-10 UA UA99031739A patent/UA60311C2/uk unknown
- 1997-09-29 DZ DZ970170A patent/DZ2320A1/xx active
- 1997-09-30 MA MA24817A patent/MA24361A1/fr unknown
- 1997-09-30 MY MYPI97004552A patent/MY137606A/en unknown
- 1997-10-01 SK SK425-99A patent/SK285029B6/sk not_active IP Right Cessation
- 1997-10-01 TR TR1999/00737T patent/TR199900737T2/xx unknown
- 1997-10-01 EP EP97909979A patent/EP0957917B1/en not_active Expired - Lifetime
- 1997-10-01 EA EA199900356A patent/EA002419B1/ru not_active IP Right Cessation
- 1997-10-01 HU HU9903769A patent/HU229221B1/hu not_active IP Right Cessation
- 1997-10-01 IL IL12924397A patent/IL129243A/en not_active IP Right Cessation
- 1997-10-01 PL PL332674A patent/PL190859B1/pl unknown
- 1997-10-01 CZ CZ0113299A patent/CZ299076B6/cs not_active IP Right Cessation
- 1997-10-01 AP APAP/P/1999/001493A patent/AP1463A/en active
- 1997-10-01 CN CN97180168A patent/CN1114403C/zh not_active Expired - Fee Related
- 1997-10-01 BR BRPI9712248-3A patent/BR9712248B1/pt not_active IP Right Cessation
- 1997-10-01 DE DE69734833T patent/DE69734833T2/de not_active Expired - Lifetime
- 1997-10-01 AU AU47462/97A patent/AU733417B2/en not_active Ceased
- 1997-10-01 AT AT97909979T patent/ATE312089T1/de active
- 1997-10-01 ID IDP973335A patent/ID19623A/id unknown
- 1997-10-01 CO CO97057225A patent/CO4900046A1/es unknown
- 1997-10-01 RO RO99-00353A patent/RO119881B1/ro unknown
- 1997-10-01 KR KR1019997002811A patent/KR100589578B1/ko not_active Expired - Fee Related
- 1997-10-01 WO PCT/US1997/018001 patent/WO1998014192A1/en not_active Ceased
- 1997-10-01 NZ NZ334953A patent/NZ334953A/xx not_active IP Right Cessation
- 1997-10-01 CA CA002267224A patent/CA2267224C/en not_active Expired - Fee Related
- 1997-10-01 ES ES97909979T patent/ES2252775T3/es not_active Expired - Lifetime
- 1997-10-01 PE PE1997000876A patent/PE10499A1/es not_active Application Discontinuation
- 1997-10-01 DK DK97909979T patent/DK0957917T3/da active
- 1997-10-01 JP JP51694298A patent/JP4491072B2/ja not_active Expired - Fee Related
- 1997-10-01 UY UY24735A patent/UY24735A1/es not_active IP Right Cessation
- 1997-10-02 AR ARP970104549A patent/AR008878A1/es active IP Right Grant
-
1998
- 1998-02-10 TW TW086114545A patent/TW487702B/zh not_active IP Right Cessation
- 1998-03-01 SA SA98180936A patent/SA98180936B1/ar unknown
- 1998-03-25 UY UY24935A patent/UY24935A1/es not_active IP Right Cessation
-
1999
- 1999-03-31 NO NO19991590A patent/NO320194B1/no not_active IP Right Cessation
- 1999-03-31 BG BG103299A patent/BG64581B1/bg unknown
-
2007
- 2007-05-18 CY CY0700010A patent/CY2576B1/xx unknown
-
2009
- 2009-10-09 JP JP2009235447A patent/JP2010006838A/ja active Pending